Intrathecal baclofen treatment in dystonic cerebral palsy: a randomized clinical trial: the IDYS trial

BACKGROUND: Dystonic cerebral palsy is primarily caused by damage to the basal ganglia and central cortex. The daily care of these patients can be difficult due to dystonic movements. Intrathecal baclofen treatment is a potential treatment option for dystonia and has become common practice. Despite...

全面介紹

書目詳細資料
Autores principales: Bonouvrié, Laura A, Becher, Jules G, Vles, Johannes SH, Boeschoten, Karin, Soudant, Dan, de Groot, Vincent, van Ouwerkerk, Willem JR, Strijers, Rob LM, Foncke, Elisabeth, Geytenbeek, Joke, van de Ven, Peter M, Teernstra, Onno, Vermeulen, R Jeroen
格式: Online Artículo Texto
語言:English
出版: BioMed Central 2013
主題:
Study Protocol
在線閱讀:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840690/
https://www.ncbi.nlm.nih.gov/pubmed/24165282
http://dx.doi.org/10.1186/1471-2431-13-175

因特網

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840690/
https://www.ncbi.nlm.nih.gov/pubmed/24165282
http://dx.doi.org/10.1186/1471-2431-13-175

相似書籍